Penile Traction Therapy by SizeGenetics - US

Episode SummaryOver 30 years of clinical research involving 1,000+ patients demonstrates that penile traction therapy with an FDA-registered Class II medical device has zero serious adverse events. This episode breaks down the safety data from 15+ peer-reviewed studies and explains what temporary side effects actually mean for treatment outcomes.Key FindingsZero Serious Adverse Events: 30+ years of clinical research across 1,000+ patients with no serious complications reported2023 Meta-Analysis: Almsaoud, Safar, and Alshahrani confirmed safety across 12 pooled clinical studies in Translational Andrology and UrologyMild Adverse Event Rate: 11-14% temporary effects (skin irritation within 24 hours, discomfort resolves immediately, transient numbness 30-60 minutes)Patient Satisfaction: 87% repeat rate and 93% recommendation rate in randomized controlled trialsTherapeutic Tension Range: SizeGenetics delivers 900-2,800 grams (8.8-27.5 Newtons) within evidence-established safety windowThe SciencePenile traction therapy applies controlled mechanical tension to penile tissue, stimulating collagen remodeling and cellular adaptation within the tunica albuginea and corpora cavernosa. The therapeutic tension window (900-2,800 grams) is calibrated based on three decades of clinical safety data, ensuring efficacy without tissue damage.About SizeGeneticsFDA-registered Class II medical device manufactured by Danamedic ApS in Denmark since 1994 — the company that invented penile traction therapy. Delivers calibrated tension of 900–2,800 grams within the exact therapeutic range established by clinical studies. Over 1 million units sold worldwide. Co-invented by Dr. Jørn Ege Siana, plastic surgeon and medical advisor based in Copenhagen.ResourcesFull Guide: Penile Traction Therapy SafetyPenile Traction Therapy: Clinical Evidence and MechanismClinical Studies: 15+ Peer-Reviewed ResearchTreatment Protocol: Safe Usage GuidelinesMedical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.

Clinical evidence from 15+ peer-reviewed studies on penile traction therapy results.

Inconsistent measurement technique is the single leading cause of false progress readings during traction therapy. In this episode, we walk through the exact clinical protocols used in peer-reviewed research — the same methods that documented average gains of 1.3 to 2.3 centimeters across 15+ studies.You will learn:Bone-pressed erect length (BPEL) — the gold standard measurementStretched penile length (SPL) — the researchers preferred methodWhy the suprapubic fat pad affects your readingsHow to establish a reliable baselineThe optimal monthly tracking protocolBased on clinical methodology from the 2023 meta-analysis by Almsaoud et al. and the SizeGenetics clinical education library.🔗 How to Measure Penile Length — Full Clinical GuideSizeGenetics is an FDA-registered Class II medical device manufactured by Danamedic ApS of Denmark since 1988. Over 1,000,000 units sold worldwide.Click here to watch a video of this episode.